AlirezaNamiMDFACR

Clinical Trials

• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus Start of enrollment: 2010 Dec 01

  Completed

  Phase 3

• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Dec 01

  Completed

  Phase 3

• Clinical Trial Treatment in Lupus Nephritis Start of enrollment: 2011 Feb 01

  Withdrawn

  Phase 3

• Corrona Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry Start of enrollment: 2002 Feb 01

  Enrolling by invitation

• Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus Start of enrollment: 2012 Jan 01

  Completed

  Phase 2

• Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study Start of enrollment: 2010 Oct 01

  Completed

• A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib Start of enrollment: 2012 Jul 01

  Completed

  Phase 1

• Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry Start of enrollment: 2013 Feb 21

  Active, not recruiting

• An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults Start of enrollment: 2013 Mar 28

  Completed

  Phase 2

• A Non-drug Study Profiling Cutaneous Lupus Start of enrollment: 2013 Apr 01

  Completed

• A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants Start of enrollment: 2013 Sep 05

  Completed

  Phase 3

• A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy Start of enrollment: 2013 Oct 01

  Completed

  Phase 2

• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01

  Terminated

  Phase 3

• Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome Start of enrollment: 2014 Aug 01

  Completed

  Phase 3

• AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) Start of enrollment: 2014 Jun 01

  Completed

  Phase 2

• Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice Start of enrollment: 2014 Aug 12

  Completed

• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus Start of enrollment: 2014 Nov 13

  Completed

  Phase 2

• A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) Start of enrollment: 2015 Apr 28

  Completed

  Phase 2

• Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission Start of enrollment: 2015 Feb 20

  Completed

  Phase 3

• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Start of enrollment: 2015 Mar 03

  Completed

  Phase 3

• Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2015 Jun 09

  Completed

  Phase 3

• A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) Start of enrollment: 2015 Nov 20

  Completed

  Phase 3

• A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice Start of enrollment: 2017 Jan 26

  Terminated

• A Study on Rheumatoid Arthritis Patients Treated With Rituximab Start of enrollment: 2008 Apr 01

  Completed

• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 29

  Completed

  Phase 3

• A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs Start of enrollment: 2016 Mar 22

  Completed

  Phase 2, Phase 3

• A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions Start of enrollment: 2016 Mar 01

  Active, not recruiting

  Phase 3

• Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus Start of enrollment: 2016 Jun 30

  Completed

  Phase 3

• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2016 Oct 20

  Completed

  Phase 2

• Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment Start of enrollment: 2016 Jul 27

  Completed

  Phase 3

• Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy Start of enrollment: 2016 Aug 08

  Completed

  Phase 3

• A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations Start of enrollment: 2017 Feb 14

  Completed

  Phase 2

• Aurinia Renal Response in Active Lupus With Voclosporin Start of enrollment: 2017 May 17

  Completed

  Phase 3

• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis Start of enrollment: 2017 Feb 28

  Active, not recruiting

  Phase 3

• A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE Start of enrollment: 2018 Mar 01

  Completed

  Phase 3

• Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care Start of enrollment: 2018 Jan 10

  Completed

  Phase 1, Phase 2

• Join now to see all